Stephen P Juraschek1, Eliseo Guallar, Lawrence J Appel, Edgar R Miller. 1. Johns Hopkins School of Medicine, Johns Hopkins Bloomberg School of Public Health, and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA.
Abstract
BACKGROUND: In observational studies, increased vitamin C intake, vitamin C supplementation, and higher blood concentrations of vitamin C are associated with lower blood pressure (BP). However, evidence for blood pressure-lowering effects of vitamin C in clinical trials is inconsistent. OBJECTIVE: The objective was to conduct a systematic review and meta-analysis of clinical trials that examined the effects of vitamin C supplementation on BP. DESIGN: We searched Medline, EMBASE, and Central databases from 1966 to 2011. Prespecified inclusion criteria were as follows: 1) use of a randomized controlled trial design; 2) trial reported effects on systolic BP (SBP) or diastolic BP (DBP) or both; 3) trial used oral vitamin C and concurrent control groups; and 4) trial had a minimum duration of 2 wk. BP effects were pooled by random-effects models, with trials weighted by inverse variance. RESULTS: Twenty-nine trials met eligibility criteria for the primary analysis. The median dose was 500 mg/d, the median duration was 8 wk, and trial sizes ranged from 10 to 120 participants. The pooled changes in SBP and DBP were -3.84 mm Hg (95% CI: -5.29, -2.38 mm Hg; P < 0.01) and -1.48 mm Hg (95% CI: -2.86, -0.10 mm Hg; P = 0.04), respectively. In trials in hypertensive participants, corresponding reductions in SBP and DBP were -4.85 mm Hg (P < 0.01) and -1.67 mm Hg (P = 0.17). After the inclusion of 9 trials with imputed BP effects, BP effects were attenuated but remained significant. CONCLUSIONS: In short-term trials, vitamin C supplementation reduced SBP and DBP. Long-term trials on the effects of vitamin C supplementation on BP and clinical events are needed.
BACKGROUND: In observational studies, increased vitamin C intake, vitamin C supplementation, and higher blood concentrations of vitamin C are associated with lower blood pressure (BP). However, evidence for blood pressure-lowering effects of vitamin C in clinical trials is inconsistent. OBJECTIVE: The objective was to conduct a systematic review and meta-analysis of clinical trials that examined the effects of vitamin C supplementation on BP. DESIGN: We searched Medline, EMBASE, and Central databases from 1966 to 2011. Prespecified inclusion criteria were as follows: 1) use of a randomized controlled trial design; 2) trial reported effects on systolic BP (SBP) or diastolic BP (DBP) or both; 3) trial used oral vitamin C and concurrent control groups; and 4) trial had a minimum duration of 2 wk. BP effects were pooled by random-effects models, with trials weighted by inverse variance. RESULTS: Twenty-nine trials met eligibility criteria for the primary analysis. The median dose was 500 mg/d, the median duration was 8 wk, and trial sizes ranged from 10 to 120 participants. The pooled changes in SBP and DBP were -3.84 mm Hg (95% CI: -5.29, -2.38 mm Hg; P < 0.01) and -1.48 mm Hg (95% CI: -2.86, -0.10 mm Hg; P = 0.04), respectively. In trials in hypertensiveparticipants, corresponding reductions in SBP and DBP were -4.85 mm Hg (P < 0.01) and -1.67 mm Hg (P = 0.17). After the inclusion of 9 trials with imputed BP effects, BP effects were attenuated but remained significant. CONCLUSIONS: In short-term trials, vitamin C supplementation reduced SBP and DBP. Long-term trials on the effects of vitamin C supplementation on BP and clinical events are needed.
Authors: Patrick H McNulty; Bryan J Robertson; Mark A Tulli; Joshua Hess; Lisa A Harach; Sofia Scott; Lawrence I Sinoway Journal: J Appl Physiol (1985) Date: 2007-02-15
Authors: Aletta E Schutte; Hugo W Huisman; Welma Oosthuizen; Johannnes M van Rooyen; Johann C Jerling Journal: Int J Vitam Nutr Res Date: 2004-07 Impact factor: 1.784
Authors: Howard D Sesso; Julie E Buring; William G Christen; Tobias Kurth; Charlene Belanger; Jean MacFadyen; Vadim Bubes; JoAnn E Manson; Robert J Glynn; J Michael Gaziano Journal: JAMA Date: 2008-11-09 Impact factor: 56.272
Authors: Angus K Nightingale; Jenifer G Crilley; Nicholas C Pegge; Ernie A Boehm; Catherine Mumford; Doris J Taylor; Peter Styles; Kieran Clarke; Michael P Frenneaux Journal: Eur J Heart Fail Date: 2006-10-04 Impact factor: 15.534
Authors: Edgar R Miller; Lisa A Cooper; Kathryn A Carson; Nae-Yuh Wang; Lawrence J Appel; Debra Gayles; Jeanne Charleston; Karen White; Na You; Yingjie Weng; Michelle Martin-Daniels; Barbara Bates-Hopkins; Inez Robb; Whitney K Franz; Emily L Brown; Jennifer P Halbert; Michael C Albert; Arlene T Dalcin; Hsin-Chieh Yeh Journal: Am J Prev Med Date: 2015-08-29 Impact factor: 5.043